1. FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression
- Author
-
Xiaohai Wang, Yiming Su, Bang-Min Han, Yu Zhang, Wenhao Zhou, Jing Zhao, and Wenhao Wang
- Subjects
Hepatocyte Nuclear Factor 3-alpha ,Male ,Cancer Research ,Angiogenesis ,Gene Expression ,Mice, Nude ,Cell Communication ,Metastasis ,Mice ,Prostate cancer ,Cell Line, Tumor ,Human Umbilical Vein Endothelial Cells ,Animals ,Humans ,Medicine ,Cell Proliferation ,Tube formation ,Mice, Inbred BALB C ,Tissue microarray ,Neovascularization, Pathologic ,business.industry ,Endothelial Cells ,Prostatic Neoplasms ,Cancer ,General Medicine ,Endoglin ,medicine.disease ,Coculture Techniques ,Endothelial stem cell ,HEK293 Cells ,Oncology ,Cancer research ,Heterografts ,Angiogenesis Inducing Agents ,business - Abstract
FOXA1, as a pioneering transcription factor, has been shown to drive prostate cancer progression. Previous studies showed that FOXA1 expression in prostate cancer was positively associated with cancer angiolymphatic invasion and metastasis. However, the mechanism underlying the correlation between FOXA1 and prostate cancer angiolymphatic invasion and metastasis remains largely unclear. Herein, we set out to investigate the role of FOXA1 in the interactions between prostate cancer cells and endothelial cells. Endothelial cells' phenotypes were assessed through CCK‐8 assay, Transwell migration assay, and tube formation assay. The angiogenic factors acting on endothelial cells mediated by FOXA1were characterized by RNA-seq, qPCR array, angiogenesis cytokines array, and ELISA assay. The impact of FOXA1 on tumor angiogenesis was examined in a xenograft model in nude mice. The effect of FOXA1 on prostate cancer angiogenesis was validated on a primary prostate cancer tissue microarray. FOXA1 expression in prostate cancer cells promoted endothelial cell proliferation, migration, and tube formation in vitro. Mechanistically, FOXA1 increased pro-angiogenic factors production, including EGF, Endothelin-1, and Endoglin. Moreover, in vivo study showed that FOXA1 facilitated tumor angiogenesis. Furthermore, clinical samples investigation indicated that FOXA1 enhanced prostate cancer angiogenesis. Overall, these findings illustrated a tumor angiogenesis-promoting role of FOXA1 in prostate cancer.
- Published
- 2021
- Full Text
- View/download PDF